Tadalafil Market Size, Share, By Purity (98%, and Above 98%), By Form (Tablet and Capsule), By Application (Erectile Dysfunction, Benign Prostatic Hyperplasia, and Pulmonary Arterial Hypertension), and By Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America) - Trends, Analysis, and Forecast till 2034

Report Code: PMI537624 | Publish Date: June 2024 | No. of Pages: 187

Tadalafil Market Companies

  • Glenmark Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Co. Pvt. Ltd.
  • Cadila Pharmaceuticals Ltd.
  • Cipla Ltd.
  • Torrent Pharma
  • Camber Pharmaceuticals
  • Dr. Reddy’s Laboratories

Recent News:

  • In March 2024, Zydus Lifesciences Limited stated that it had received final permission from the US Food and Drug Administration (USFDA) to commercialize its Finasteride and Tadalafil Capsules USP 5 mg/5 mg. Zydus said in a statement that the company's formulation manufacturing plant in Gujarat's Ahmedabad SEZ II will create this drug, which is used to treat benign prostatic hyperplasia.
  • In September 2023, Akums Drugs and Pharmaceuticals, after receiving clearance from the Drug Controller General of India (DCGI) for the formulation of Tamsulosin 0.4/0.4 mg + Tadalafil 2.5/5 mg, introduced Tamsulosin + Tadalafil Capsules in the Indian market.